ClinicalTrials.govpublic full text
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive
cervical cancer, renal cancer, urothelial cancer, melanoma, breast cancer, gene therapy, tumor regression, immunotherapy, adoptive cell therapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800372
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.